Orpea: Feedback RS focus on Orpea’s expansion
Orpea: (BUY-TOP PICKS, Fair Value EUR125 (+7%))Feedback RS focus on Orpea’s expansion
After accelerated international expansion, mainly realized in Europe and the adaptation of its organization with a strong decentralization under the control of the head office, the group is now targeting new countries, particularly in Latin America with an initial presence in Brazil. The opening of a new country is based on three criteria that must be in adequacy (purchasing power, labour cost and real estate cost) in order to provide an EBITDAR margin between 25 and 35% and EBITDA asset light of more than 10%. Taking into account Orpea’s track record, international expansion outside Europe can be considered a new growth driver.
ORPEA is a dependency, physical and psychiatric care group based in France. Co. operates long-term and short-term care facilities, including medical care facilities, medical and social care facilities and residential facilities for the elderly. Co. provides short, medium and long-term global physical and mental dependency care. Co. also operates residential facilities for disabled people of any age, hotels, and hotel-related, as well as leisure accommodation facilities. Co. operates in France and abroad (Belgium, Italy, Spain and Switzerland) in three business segments: Long-term care facilities (nursing homes); Post-acute and Rehabilitation care facilities; and Psychiatric care facilities.
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.